The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Platelets

• Publication date

  2001-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/09537100120078368PMID 11674859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxidative stress and glycemic regulation.

  2000cited by this paper
• Increased leukocyte-platelet adhesion in chronic myeloproliferative disorders with high platelet counts.

  2000cited by this paper
• The post‐prandial state and cardiovascular disease: relevance to diabetes mellitus

  2000cited by this paper
• Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering.

  1999cited by this paper
• Meal-Generated Oxidative Stress in Type 2 Diabetic Patients

  1998cited by this paper
• Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment.

  1997cited by this paper
• Role of PSGL-1 binding to selectins in leukocyte recruitment.

  1997cited by this paper
• Platelet-leukocyte-cross-talk in diabetes mellitus.

  1997cited by this paper
• Adhesion molecules influencing atherosclerosis.

  1996cited by this paper
• Post-meal coagulation activation in diabetes mellitus: the effect of acarbose

  1996cited by this paper
• The Activated Megakaryocyte-Platelet-System Vascular Disease: Focus on Diabetes

  1995cited by this paper
• Polymorphonuclear Leukocyte-Platelet Interaction: Role of P-Selectin in Thromboxane B2 and Leukotriene C4 Cooperative Synthesis

  1994cited by this paper
• Platelet-leukocyte aggregation during hemodialysis.

  1994cited by this paper
• Interaction Between Glycosaminoglycans, Platelets, and Leukocytes

  1994cited by this paper
• The megakaryocyte platelet system and vascular disease

  1994cited by this paper
• Platelets in Diabetes: The Role in the Hemostatic Regulation in Atherosclerosis

  1993cited by this paper
• Cardiopulmonary bypass induces leukocyte-platelet adhesion.

  1992cited by this paper
• Dynamics of leukocyte-platelet adhesion in whole blood.

  1991cited by this paper
• Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.

  1991cited by this paper
• Large Platelets Circulate in an Activated State in Diabetes Mellitus

  1991cited by this paper
• PADGEM-dependent adhesion of platelets to monocytes and neutrophils is mediated by a lineage-specific carbohydrate, LNF III (CD15).

  1990cited by this paper
• Evidence for abnormal platelet glycoprotein expression in diabetes mellitus

  1990cited by this paper

• Platelet-leukocyte aggregates in cardiovascular disease: prognostic significance and therapeutic potential.

  2025cites this paper
• Hyperactivity and Pro-inflammatory Functions of Platelets in Diabetes.

  2025cites this paper
• Possible role of platelet-monocyte complexes in the pathogenesis of recurrent pregnancy loss

  2025cites this paper
• Platelet-Neutrophil Interactions and Thrombo-inflammatory Complications in Type 2 Diabetes Mellitus

  2022cites this paper
• Application Value of Neutrophil to Lymphocyte Ratio in Diabetic Retinopathy

  2022cites this paper
• Hyper-reactive platelets and type 2 diabetes.

  2022cites this paper
• P2Y12 Inhibition Suppresses Proinflammatory Platelet–Monocyte Interactions

  2022cites this paper
• Platelet-leukocyte interactions: immunoregulatory role and pathophysiological relevance

  2022cites this paper
• Association of the Monocyte–to–High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy

  2021cites this paper
• Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease

  2021cites this paper
• Significance of Neutrophil to Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) in Diabetic Foot Ulcer and Potential New Therapeutic Targets

  2021cites this paper
• The unique association between the level of peripheral blood monocytes and the prevalence of diabetic retinopathy: a cross-sectional study

  2020cites this paper
• Hyperglycaemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus

  2016cites this paper
• Haemodiafiltration elicits less platelet activation compared to haemodialysis

  2016cites this paper
• Postprandial activation of platelets as a possible mechanism for the development of atherosclerosis

  2016cites this paper
• Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease.

  2015cites this paper
• Overview of Platelet Physiology: Its Hemostatic and Nonhemostatic Role in Disease Pathogenesis

  2014cites this paper
• PLATELET ACTIVATION AND ASSOCIATED TRANSCRIPTIONAL SIGNATURE IN TYPE 2 DIABETIC PATIENTS WITH STABLE CORONARY ARTERY DISEASE: INSIGHTS INTO THEIR THROMBOTIC PROPENSITY.

  2014cites this paper
• Monocyte subsets in heart failure

  2013influential citation
• Flow Cytometric Investigation of Classical and Alternative Platelet Activation Markers

  2013cites this paper
• [Diabetes mellitus as hypercoagulate state: ways of preventing].

  2013cites this paper
• Platelet Cd Markers By Flow Cytometry In Normal Individuals And In Patients With Untreated Type 2 Diabetes Mellitus

  2013cites this paper
• The effect of the flavonols quercetin and 3', 4' dihydroxyflavonol on platelet function in vitro and in vivo

  2012cites this paper
• Elevation of monocyte-platelet aggregates is an early marker of type 2 diabetes.

  2012cites this paper
• Effects of lipid-lowering treatment on platelet reactivity and platelet-leukocyte aggregation in diabetic patients without and with chronic kidney disease: a randomized trial.

  2012cites this paper
• A contemporary viewpoint on ‘aspirin resistance’

  2012cites this paper
• Platelet activation markers after conversion from azathioprine to sirolimus based immunosuppression in renal transplant recipients.

  2012cites this paper
• Overcoming aspirin treatment failure in diabetes

  2012cites this paper
• Ethnic differences in endothelial function and monocyte subsets in heart failure

  2012cites this paper
• Platelet function and signaling in diabetes mellitus.

  2012cites this paper
• Roles of Mac-1 and glycoprotein IIb/IIIa integrins in leukocyte–platelet aggregate formation: Stabilization by Mac-1 and inhibition by GpIIb/IIIa blockers

  2012cites this paper
• Critical Reviews in Clinical Laboratory Sciences

  2012cites this paper
• Rare homozygous status of P43 β1-tubulin polymorphism causes alterations in platelet ultrastructure

  2011cites this paper
• Levels of Platelet-Leukocyte Aggregates in Women With Both Thrombophilia and Recurrent Pregnancy Loss

  2011cites this paper
• Lack of P-selectin glycoprotein ligand-1 protects mice from thrombosis after collagen/epinephrine challenge.

  2011cites this paper
• Systemic Evaluation of Platelet and Leukocyte Activation and Interaction in a Rat Model of Pulmonary Arterial Hypertension

  2010cites this paper
• The role of monocytes in atherosclerotic coronary artery disease

  2010cites this paper
• Nephropathy in Type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity

  2009cites this paper
• The role of monocytes in thrombotic disorders

  2009cites this paper
• Citometría de flujo de plaquetas en la diabetes mellitus y otras patologías metabólico-vasculares

  2009cites this paper
• Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients.

  2008cites this paper
• Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles.

  2008cites this paper
• Status of platelet-lymphocyte aggregation in circulating blood of patients with type 1 diabetes with and without diabetic nephropathy.

  2008cites this paper
• Expression, activation, and function of integrin (cid:1) M (cid:2) 2 (Mac-1) on neutrophil-derived microparticles

  2008cites this paper
• CHAPTER 38 – Diabetes Mellitus

  2007cites this paper
• Leukocytes in diabetic retinopathy.

  2007cites this paper
• ThromboFix™ Platelet Stabilizer: Advances in clinical platelet analyses by flow cytometry?

  2006cites this paper
• Elevation of monocyte-derived microparticles in patients with diabetic retinopathy.

  2006cites this paper
• The changes of leukocyte-platelet mixed aggregates formation, platelet EDRF/NO production, and haemorheology in diabetes mellitus, their role in the pathogenesis of diabetic angiopathy

  2006cites this paper
• Diabetes mellitus und das Gerinnungssystem

  2005cites this paper
• PLATELET FUNCTION IN DIABETES MELLITUS

  2005cites this paper
• Increased levels of platelet-derived microparticles in patients with diabetic retinopathy.

  2005cites this paper
• Platelet-monocyte aggregates are independently associated with occurrence of carotid plaques in type 2 diabetic patients.

  2005cites this paper
• Platelet Activation and Platelet-Leucocyte Interaction in Patients with Migraine. Subtype Differences and Influence of Triptans

  2005cites this paper
• Pathobiology and cell interactions of platelets in diabetes

  2005cites this paper
• Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus.

  2005cites this paper
• Increased platelet activation in young Zucker rats with impaired glucose tolerance is improved by acarbose

  2004cites this paper
• Platelet activity, reactivity and platelet-leukocyte conjugate formation before and after exhaustive or moderate exercise in patients with IDDM

  2004cites this paper
• Enhanced leukocyte–platelet cross‐talk in Type 1 diabetes mellitus: relationship to microangiopathy

  2004cites this paper
• The emerging value of P-selectin as a disease marker

  2004cites this paper
• Differentiation of platelet–leukocyte conjugate formation by short term exercise

  2004cites this paper
• Reduced Vascular NO Bioavailability in Diabetes Increases Platelet Activation In Vivo

  2004cites this paper
• Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus

  2004cites this paper
• Platelet Count Neither Decreases nor Relates to Blood Glucose Level

  2004cites this paper
• Protein kinase C beta2-dependent phosphorylation of core 2 GlcNAc-T promotes leukocyte-endothelial cell adhesion: a mechanism underlying capillary occlusion in diabetic retinopathy.

  2003cites this paper
• INFLAMMATION IN DIABETIC WOMEN WITH CARDIOVASCULAR DISEASE

  2003cites this paper
• Short-term exercise and platelet activity, sensitivity to agonist, and platelet-leukocyte conjugate formation

  2003cites this paper
• Paraformaldehyde fixation induces a systematic activation of platelets

  2003cites this paper
• Platelet activity, sensitivity to agonist, and platelet-leukocyte conjugate formation after long-term exercise

  2002cites this paper
• Review: Diabetes as a procoagulant condition

  2002cites this paper
• Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus

  2002cites this paper
• Mechanisms involved in platelet hyperactivation and platelet-endothelium interrelationships in diabetes mellitus

  2002cites this paper